Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (for routine co-testing in women over 30)
FDA-approved test for cotesting at 5-year intervals in individuals 25-65 years with a cervix. Preferred test is Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (3003005).
Microscopy/Qualitative Nucleic Acid Amplification
1-7 days, add 2 days for HPV testing
New York DOH Approval Status
Transport cervical specimen in the original collection kit.
Specimens not collected in a ThinPrep Pap Test collection kit or specimens submitted in an expired collection kit.
Ambient: 3 weeks; Refrigerated: 3 weeks; Frozen: Unacceptable
Refer to report.
In addition to the ThinPrep Pap Test, Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (ARUP test code 3003005) will be performed and reported under a separate accession. Additional charges apply. The Pap Test is a screening test for cervical cancer and its precursors with an inherent false-negative rate.
88142; if reviewed by pathologist add 88141; 87624
|Component Test Code*||Component Chart Name||LOINC|
|2000530||ThinPrep Pap Specimen Source|
- Pap Smear
- Thin Prep reflex HPV
- ThinPrep Pap
- ThinPrep Pap and HPV HR E6/E7
- ThinPrep Pap Test with reflex to HR HPV
- ThinPrep Reflex to HPV